Checkpoint Inhibitor-Induced Colitis: An Update

Checkpoint Inhibitor-Induced Colitis: An Update

Immunotherapy with immune checkpoint inhibitors (ICIs) nowadays has indications for several solid tumors. The current targets for ICIs are CTLA-4, PD-1, and PD-L1 receptors. Despite the clinical advantages derived from ICIs, a variety of side effects are linked to overstimulation of the immune syste...

Full description

Bibliographic Details
Main Authors: Giuseppe Losurdo, Daniele Angelillo, Nicolas Favia, Maria Chiara Sergi, Alfredo Di Leo, Giacomo Triggiano, Marco Tucci
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Biomedicines
Subjects:
immunotherapy
cancer
immune checkpoint inhibitors
colitis
diarrhea
Online Access:https://www.mdpi.com/2227-9059/11/5/1496

Internet

https://www.mdpi.com/2227-9059/11/5/1496

Similar Items